Propiedad y actividad de insiders de Matinas BioPharma Holdings, Inc. (MTNB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.17 |
| Capitalización | $1M |
| Bolsa | AMEX |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $4.1M | $7.3M | $12.4M | $22.2M | $12.4M | $21.0M | $6.9M | $4.8M | $7.3M | $4.0M |
| Inversiones a Corto | 0 | 0 | 0 | $5.6M | $46.2M | $28.6M | $21.9M | $9.0M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.6M | $8.0M | $13.1M | $29.9M | $61.6M | $51.0M | $34.5M | $15.5M | $8.0M | $4.1M |
| Inmovilizado Material | $356000 | $1.6M | $2.0M | $5.6M | $4.9M | $5.8M | $5.7M | $5.0M | $2.2M | $673000 |
| Fondo de Comercio | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | 0 | 0 |
| Activos Intangibles | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $2.3M | $2.3M |
| Activos Totales | $9.8M | $14.4M | $19.9M | $40.2M | $71.0M | $61.3M | $78.9M | $25.1M | $12.6M | $7.2M |
| Cuentas por Pagar | $475602 | $582867 | $295652 | $679310 | $349941 | $937000 | $618000 | $514000 | $95000 | $315000 |
| Deuda a Corto | $118046 | $170236 | $199842 | 0 | 0 | 0 | $569000 | 0 | 0 | $696000 |
| Pasivos Corrientes | $1.4M | $2.2M | $2.8M | $3.1M | $3.6M | $4.3M | $4.3M | $2.6M | $2.7M | $1.5M |
| Deuda a Largo | 0 | 0 | 0 | $3.75B | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.7M | $3.7M | $3.8M | $7.2M | $7.2M | $8.8M | $42.2M | $5.9M | $5.1M | $2.4M |
| Reservas | -$35.2M | -$51.3M | -$65.9M | -$84.4M | -$107.5M | -$131.6M | -$152.6M | -$175.6M | -$199.8M | -$210.8M |
| Patrimonio Neto | $7.1M | $10.7M | $16.1M | $33.1M | $63.7M | $52.5M | $36.6M | $19.2M | $7.6M | $4.8M |
| Deuda Total | $144428 | $264894 | $390743 | $4.2M | $3.8M | $4.7M | $4.1M | $3.6M | $2.9M | $1.4M |
| Deuda Neta | -$4.0M | -$7.0M | -$12.1M | -$23.5M | -$54.9M | -$44.9M | -$24.7M | -$10.2M | -$4.4M | -$2.6M |
| Capital Circulante | $3.1M | $5.7M | $10.2M | $26.8M | $58.0M | $46.6M | $30.2M | $12.9M | $5.4M | $2.6M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 0.85 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -42.88 |
Rentabilidad
| Rentabilidad sobre capital | -181.45% |
| Rentabilidad sobre capital invertido | -323.22% |
| Rentabilidad sobre activos | -214.21% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACXP · ADIL · ADXN · BCLI · CDIO · HCWB · IBO
Explorar sector: Healthcare · Biotechnology
Más secciones de MTNB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones